local_hospital

General Hospital of Nikaia-Piraeus, “Agios Panteleimon”

Address
lock Available on a paid plan

Digestive System Diseases and Inflammatory Bowel Disease Research

At General Hospital of Nikaia-Piraeus, “Agios Panteleimon”, clinical research in digestive system diseases focuses on Crohn’s Disease and the search for better ways to control inflammation in adults who have not responded well to earlier treatment. These studies are designed to compare the effectiveness and safety of new therapy options and to support longer-term disease management.

  • Comparing treatment effectiveness in Crohn’s Disease
  • Evaluating long-term safety in gastroenterology
  • Supporting sustained access to care for patients with chronic intestinal inflammation

This area reflects a strong interest in improving outcomes for people living with persistent inflammatory bowel disease, with attention to both symptom control and treatment safety over time.

Diseases of the Kidneys and Pathological Conditions

Research in IgA Nephropathy at this site aims to better understand how to reduce kidney damage and protein loss in adults affected by this immune-mediated renal disease. The trials are centered on testing whether new treatment approaches can improve disease control and protect kidney function.

  • Studying proteinuria reduction in IgA Nephropathy
  • Assessing potential new options for kidney disease treatment
  • Exploring ways to slow progression of chronic renal injury

This work highlights a focused effort in nephrology to improve both measurable kidney outcomes and overall patient care.

Respiratory Tract Diseases and Infection Management

The site also conducts studies in community-acquired pneumonia and severe infections, with an emphasis on improving diagnosis and guiding antibiotic use more effectively. These trials seek to reduce unnecessary broad-spectrum treatment and help prevent worsening illness, including progression to sepsis.

  • Improving treatment decisions in community-acquired pneumonia
  • Reducing overuse of antibiotics in serious infections
  • Testing biomarker-guided approaches for earlier infection control

This research combines respiratory medicine and infectious disease expertise to support more targeted and timely care for patients at higher risk.

Musculoskeletal Diseases and Knee and Back Pain Research

In the department of Sports Injuries and Knee Surgery, studies in musculoskeletal diseases include work on low back pain, a common condition that can significantly limit daily activity. The trials are aimed at evaluating whether new pain-relief strategies can improve comfort and function more effectively than existing options.

  • Testing treatment options for acute severe low back pain
  • Comparing pain relief and tolerability approaches
  • Supporting better management of movement-related pain

This area shows a practical focus on orthopedic and pain management research that may help patients recover mobility and return to normal activities sooner.

Bacterial Infections and Mycoses and Clinical Biomarker Research

Another important part of the research portfolio involves bacterial infections, where trials are examining ways to improve the diagnosis and treatment of severe infectious illness. The main purpose is to make therapy more precise by using clinical indicators that can guide decisions earlier in the course of care.

  • Evaluating tools for earlier infection diagnosis
  • Improving targeted treatment for severe infections
  • Supporting safer and more effective antimicrobial use

This line of research brings together microbiology and clinical decision support to help clinicians choose treatments that are more precise and potentially more effective.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
6
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 173 other sites in Greece

description
Trial volume
2
Outperforms 39% of sites
public
Therapeutic diversity
2areas
Outperforms 45% of sites
groups
Sponsor diversity
2sponsors
Outperforms 42% of sites

Therapeutic Area Benchmark — Greece

Select a therapeutic area to compare against other sites in Greece.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Greece

Market Share

Country: Greece

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in General Hospital of Nikaia-Piraeus, “Agios Panteleimon”

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Atacicept in Adult Patients with IgA Nephropathy: A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled StudyVera Therapeutics Inc.Phase IVNot RecruitingSep 2021

IMP list

lock Showing 1 of 6 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Atacicept1Unknown2021-09-152021-09-15

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.